MetaCap

Aura Biosciences (AURA) News

NASDAQ: AURAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

6.87-0.11 (-1.58%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

AURA news summary

We found 6 recent headlines mentioning Aura Biosciences (AURA): 2 in the past week and 6 in the past 30 days, most often from GlobeNewswire, Nasdaq, Seeking Alpha. For price context, AURA is down 1.58% at $6.87. The most recent story, "OXB confirms partnership with Aura Biosciences supporting Phase 3 development and future commercial supply of lead oncology candidate", was published by GlobeNewswire on Nov 17, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Aura Biosciences headlines

Compare AURA